Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia.

[1]  A. Santos-Silva,et al.  Bilirubin Dependence on UGT1A1 Polymorphisms, Hemoglobin, Fasting Time and Body Mass Index , 2012, The American journal of the medical sciences.

[2]  A. Žák,et al.  Statin use and serum bilirubin levels. , 2011, Atherosclerosis.

[3]  P. Barter,et al.  Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999-2008. , 2011, Atherosclerosis.

[4]  J. Kastelein,et al.  Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease? , 2011, Journal of Lipid Research.

[5]  W. Durante.  Protective role of heme oxygenase-1 against inflammation in atherosclerosis. , 2011, Frontiers in bioscience.

[6]  B. Tomlinson,et al.  Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients , 2010, Pharmacogenetics and genomics.

[7]  Tae-Wook Kang,et al.  Genome-wide association of serum bilirubin levels in Korean population. , 2010, Human molecular genetics.

[8]  M Schwab,et al.  UDP‐Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo , 2010, Clinical pharmacology and therapeutics.

[9]  N. Nakamura,et al.  Low serum bilirubin concentration is associated with coronary artery calcification (CAC). , 2009, Atherosclerosis.

[10]  Ming-Huei Chen,et al.  Genome-wide association meta-analysis for total serum bilirubin levels. , 2009, Human molecular genetics.

[11]  D. Ertuğrul,et al.  Increased Levels of 25 Hydroxyvitamin D and 1,25-Dihydroxyvitamin D After Rosuvastatin Treatment: A Novel Pleiotropic Effect of Statins? , 2009, Cardiovascular Drugs and Therapy.

[12]  N. Kamatani,et al.  Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects , 2009, Journal of Human Genetics.

[13]  Ying Wang,et al.  Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations , 2009, Human mutation.

[14]  W. Brown.  Safety of statins. , 2008, Current opinion in lipidology.

[15]  R. Collins,et al.  SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.

[16]  Shing‐Jong Lin,et al.  Serum Bilirubin and Ferritin Levels Link Heme Oxygenase-1 Gene Promoter Polymorphism and Susceptibility to Coronary Artery Disease in Diabetic Patients , 2008, Diabetes Care.

[17]  H. Schwertner,et al.  Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. , 2008, Atherosclerosis.

[18]  P. Neuvonen,et al.  Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin , 2007, Clinical pharmacology and therapeutics.

[19]  J. Armitage,et al.  The safety of statins in clinical practice , 2007, The Lancet.

[20]  D. Stevenson,et al.  Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. , 2007, Canadian journal of physiology and pharmacology.

[21]  K. Erdmann,et al.  Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. , 2004, Biochemical and biophysical research communications.

[22]  J. Shyy,et al.  Simvastatin Induces Heme Oxygenase-1: A Novel Mechanism of Vessel Protection , 2004, Circulation.

[23]  D. Keppler,et al.  Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). , 2004, Pharmacogenetics.

[24]  T. Uchiumi,et al.  Trafficking and functional defects by mutations of the ATP‐binding domains in MRP2 in patients with Dubin‐Johnson syndrome , 2002, Hepatology.

[25]  B. Ma,et al.  Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[26]  E. Beutler,et al.  Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. L. White,et al.  Fasting and gender (and altitude?) influence reference intervals for serum bilirubin in healthy adults. , 1981, Clinical chemistry.

[28]  B. Zhang,et al.  Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. , 2011, Journal of atherosclerosis and thrombosis.

[29]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[30]  H. Schwertner,et al.  The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. , 2007, Advances in clinical chemistry.

[31]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..